New Actos Bladder Cancer Suit Joins Litigation
Elise Kramer | February 10th, 2012 | Posted in Actos Bladder Cancer News
Another Actos bladder cancer lawsuit is making its way through the legal system after being filed by the Actos lawyer of Silvestre Oritz. Oritz took the type 2 diabetes treatment medication for five years, from 2005 to 2010, and was diagnosed with Actos bladder cancer in February of 2010. He stopped taking Actos in July of 2010.
French Actos recall raises questions
The medication is relatively widely prescribed, and a number of patients have filed lawsuits regarding complications and Actos side effects they have experienced while taking it. One of the most common side effects mentioned in lawsuits is Actos bladder cancer. The risk for this life-threatening condition is so high that the medication has been recalled in France based on studies that showed an increased chance of bladder cancer in Actos patients.
Drug maker Takeda Pharmaceuticals, according to many lawsuits, including Oritz’s, failed to protect American patients of the medication by not issuing a similar recall to the one that took place in France. The French National Health Insurance Plan provided data on 1.5 million diabetes patients, some of whom were taking Actos, for four years between 2006 and 2009. The study showed that a significant number of men who had been exposed to Actos for more than 12 months were developing bladder cancer at a rate higher than expected.
Actos lawsuits seek damages
The Actos lawyer for plaintiff Oritz has requested that a jury be seated to hear the evidence in this new Actos bladder cancer lawsuit. Oritz and his lawyer are seeking multiple damages related to “permanent injuries and emotional distress, along with economic loss due to medical expenses, and living related expenses due to his new lifestyle” experienced by the plaintiff.
Many Actos lawsuits are citing the French recall of the medication as proof that the drug is fundamentally unsafe. A number of patients and plaintiffs are wondering why the drug has not yet been recalled in the united states due to its apparent riskiness and its definitive link to a life-threatening condition like Actos bladder cancer.
- Lawsuit Relies Heavily on French Actos Recall
- California Actos Bladder Cancer Lawsuit Alleges Deceit by Concealment
- Actos Lawsuit Filed in Georgia by Woman Who Suffers from Bladder Cancer